Press Release: Nucleai : Nucleai Highlights AI-Powered Spatial Biomarker Breakthroughs to Enhance Immunotherapy Success for Lung and Skin Cancer Patients at SITC 2024

CHICAGO--(BUSINESS WIRE)--Nucleai, an AI-powered spatial biology company, will present two abstracts at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting. The presentations will detail how Nucleai's AI-driven spatial biomarker analysis provides actionable insights into patient treatment for non-small cell lung cancer (NSCLC) and melanoma, focusing on treatment resistance and patient stratification. Spatial biology examines the organization of cells and proteins in their natural